The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALTISOURCE ASSET MGMT CORP | COM | 02153X108 | 1,986 | 63,535 | SH | SOLE | 63,535 | 0 | 0 | ||
ARRIS INTERNATIONAL PLC | SHS | G0551A103 | 4,985 | 157,691 | SH | SOLE | 123,685 | 34,006 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 7,462 | 156,400 | SH | Put | SOLE | 156,400 | 0 | 0 | |
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 5,897 | 123,600 | SH | Call | SOLE | 103,600 | 20,000 | 0 | |
CELGENE CORP | COM | 151020104 | 13,500 | 143,100 | SH | Put | SOLE | 118,100 | 25,000 | 0 | |
CELGENE CORP | COM | 151020104 | 22,676 | 240,368 | SH | SOLE | 210,128 | 30,240 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 1,472 | 27,300 | SH | Put | SOLE | 27,300 | 0 | 0 | |
CVS HEALTH CORP | COM | 126650100 | 13,639 | 252,900 | SH | Call | SOLE | 252,200 | 700 | 0 | |
CVS HEALTH CORP | COM | 126650100 | 28,928 | 536,407 | SH | SOLE | 514,419 | 21,988 | 0 | ||
INTEGRATED DEVICE TECHNOLOGY | COM | 458118106 | 9,181 | 187,400 | SH | SOLE | 160,800 | 26,600 | 0 | ||
MELLANOX TECHNOLOGIES LTD | SHS | M51363113 | 533 | 4,500 | SH | Call | SOLE | 4,500 | 0 | 0 | |
MELLANOX TECHNOLOGIES LTD | SHS | M51363113 | 23,080 | 195,000 | SH | SOLE | 163,076 | 31,924 | 0 | ||
RED HAT INC | COM | 756577102 | 46,619 | 255,167 | SH | SOLE | 234,709 | 20,458 | 0 | ||
SPARK THERAPEUTICS INC | COM | 84652J103 | 7,402 | 65,000 | SH | SOLE | 35,000 | 30,000 | 0 | ||
TAKEDA PHARMACEUTICAL CO LTD | SPONSORED ADS | 874060205 | 1,026 | 50,369 | SH | SOLE | 45,827 | 4,542 | 0 |